Background Hypothyroidism (sub-clinical and overt) and metabolic syndrome are
recognized risk factors for atherosclerotic cardiovascular disease. This study is an effort to …

Aim: Hypothyroidism and metabolic syndrome are well-associated risk factors for
atherogenic cardiovascular disease. Insulin resistance, being a common pathogenic …

Introduction: Although overt hypothyroidism is a known risk factor for cardiovascular disease,
there is no consensus regarding the impact of subclinical hypothyroidism (SCH) on …

Prior cross-sectional analyses have demonstrated an association between subclinical
hypothyroidism and metabolic syndrome and selected components. However, the temporal …

Background Thyroid dysfunction (TD) and metabolic syndrome (MetS) are known risk factors
for atherosclerotic cardiovascular disease (ASCVD). TD is risk factor for ASCVD mediated by …

Aim: Metabolic syndrome (MetS) and hypothyroidism are well established forerunners of
atherogenic cardiovascular disease. Considerable overlap occurs in the pathogenic …

The association between subclinical hypothyroidism (SCH) and metabolic syndrome (MetS)
has been widely discussed. This study aimed to conduct an update and comprehensive …

Background: Observational studies on the association between subclinical hypothyroidism
(SCH) and metabolic syndrome (MetS) have produced inconsistent results. Therefore, we …

The ssociation between coronary heart disease and subclinical hypothyroidism (SCH) is
unclear. We aimed to determine hs-CRP concentrations in patients with SCH. Seventy …

Thyrotropin levels are outside normal reference range in subclinical thyroid disease.
Metabolic syndrome (MetS) involves clustered cardiovascular risk factors, including …